Tilray Brands Inc
tilray.comWhat Do They Do?
Produces and sells beverages and cannabis products, and distributes pharmaceutical and wellness products to consumers, patients, pharmacies and pharmaceutical wholesalers.
10-K for FY2026, filed Jul 28, 2026Beverage – Production, marketing and sale of beverages.View ↗
Cannabis – Cultivation, production, distribution and sale of both medical and adult-use cannabis products.View ↗
Distribution – Purchase, resale and distribution of pharmaceutical and wellness products.View ↗
Wellness – Production, marketing and distribution of hemp-based food and other wellness products.View ↗
Build global brands that lead in their respective industries by winning the hearts and minds of our consumers. We have a house of…View ↗
Our customers include public pharmacies, hospital pharmacies, and specialized pharmacies as well as pharmaceutical wholesalers.…View ↗
How Do They Make Money?
It earns money by selling beverages, cannabis, pharmaceutical and wellness products; sales are counted when goods are transferred to customers and services are provided.
10-K for FY2026, filed Jul 28, 2026Beverage – Production, marketing and sale of beverages.View ↗
Cannabis – Cultivation, production, distribution and sale of both medical and adult-use cannabis products.View ↗
Distribution – Purchase, resale and distribution of pharmaceutical and wellness products.View ↗
Wellness – Production, marketing and distribution of hemp-based food and other wellness products.View ↗
Revenue is recognized when the control of the promised goods or services, through performance obligation, is transferred or provided to the…View ↗
$915.5M
-
10-K for FY2026, filed Jul 28, 2026
$915.5M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Beverage Alcohol Business
Sold outright
10-K for FY2026, filed Jul 28, 2026 |
28%
FY2023: 15%
|
Beverage Alcohol Business, FY2026
$254M Sources
|
Sold outright |
|
Cannabis Segment
Sold outright
10-K for FY2026, filed Jul 28, 2026 |
29%
FY2023: 35%
|
Cannabis Segment, FY2026
$268.3M Sources
|
Sold outright |
|
Distribution Business
Sold outright
10-K for FY2026, filed Jul 28, 2026 |
36%
FY2023: 41%
|
Distribution Business, FY2026
$327.2M Sources
|
Sold outright |
|
Wellness Business
Sold outright
|
7.2%
FY2023: 8.4%
|
Wellness Business, FY2026
$65.9M Sources
|
Sold outright |
Who Are Their Customers?
The distribution business sells pharmaceutical products to public, hospital and specialized pharmacies and pharmaceutical wholesalers. Medical cannabis reaches patients through company subsidiaries and established pharmaceutical distributors.
10-K for FY2026, filed Jul 28, 2026
Do Revenues Turn Into Profits?
No. It lost $121.4M in FY2026.
10-K for FY2026, filed Jul 28, 2026
How Are They Changing?
- Net income
-
Sources
10-Q for Q1 FY2027, filed Oct 8, 2026
−$43.1MView ↗
- ▲ +13298% (Loss)
- vs −$322K in Q1 FY2026
10-Q for Q1 FY2027, filed Oct 8, 2026
Open tableView ↗
Growing. Revenue grew 46% in 4 years, from $628.4M in FY2022 to $915.5M in FY2026, about 10% a year.
Global beverage reach
The older report framed craft beer and spirits investment around a U.S. platform; the latest describes BrewDog extending beverage operations and distribution into international markets.
10-K for FY2023, filed Jul 26, 2023 10-K for FY2026, filed Jul 28, 2026Grow and leverage our investment in craft beer, spirits and hemp-based food. Within the U.S., our strategic acquisitions of beverage…View ↗
Digital medical access
The earlier report described supplying medical cannabis through subsidiaries and pharmaceutical distributors; the latest adds a UK clinic and digital pharmacy platform alongside traditional prescription medicines.
10-K for FY2023, filed Jul 26, 2023 10-K for FY2026, filed Jul 28, 2026We were among the first companies to be permitted to cultivate and sell legal medical cannabis. Today, we supply high-quality medical…View ↗
Lyphe. On April 15 2026, Tilray acquired the Lyphe Group, a UK-based medical cannabis clinic and digital pharmacy platform (“Lyphe”).…View ↗
Loading...
